Tesla Launches Full SelfDriving Supervised in China Amidst Intensifying Local Competition Kevin Warsh Takes Helm as Fed Chair Amid Trumps Push for Rate Cuts Markets Expect Extended Pause Recursion Pharmaceuticals Shares Slide to 52Week Low Amid Sector Headwinds SpaceX IPO Speculation Nvidia Earnings and Bezoss AI Bubble Comments Lead Morning Market Briefing Ferrari Shares Slip After Unveiling Luce Its First AllElectric Model Analyst Favorites Highlight Earnings Growth Potential in Seven Stocks Solar Stock Breaks Key Level COUR Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand Signals Forrester Research FORR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Declines Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Losses but Revenue Remains Absent PLAG Q3 2023 Earnings Net Loss per Share Reported Amid Limited Disclosure NTGR Q1 2026 Earnings Stellar EPS Surprise of 268 Drives Stock Higher TruGolf Holdings Inc TRUG Q3 2025 Earnings Narrower Loss Surprises Shares Edge Higher Principal Real Estate Income Fund PGZ Holds Steady Near Support After Minimal Gain Lionheart Holdings CUB Creeps Up Slightly Testing 1081 Amid Quiet Trading Anterix Inc ATEX Edges Higher Amid Consolidation Key Levels to Watch John Hancock Diversified Income Fund HEQ Modest Uptick Amid Steady Support Levels Duolingo DUOL Holds Steady Near Support as Trading Volume Eases US Remains Key Market for Chinese Firms Despite Lingering Trust Issues After Tariff Easing UVV Q1 2026 Earnings EPS Misses Estimates Sharply on Cost Headwinds Expensify Inc EXFY Edges Higher Amid Consolidation Near Key Levels LiqTech International LIQT Edges Lower as Stock Tests Key Support Near 171 Clover Health CLOV Surges Over 12 as Momentum Breaks Above Key Resistance CapsoVision CV Holds Steady Near Key Support Amid Low Volatility Bank OZK Preferred Stock OZKAP Holds Steady Near Support as Trading Activity Remains Subdued MarketAxess Holdings MKTX Edges Higher Amid Cautious Trading Xperi Inc XPER Edges Higher in Quiet Trading Key Levels in Focus Clover Health CLOV Slips Below Key Level as Selling Pressure Persists